| 标题 |
 Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: results from the phase III, double-blinded, placebo- and active comparator-controlled VOYAGE 1 trial |
| 网址 | |
| DOI | |
| 其它 | 需要英文版全文 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时，文件已从服务器自动删除，无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
GingerF
Nole
Wells
秋风
cdercder
Kao
Sapphire
dew
DW
无极微光
YifanWang
Syening
Criminology34
Anonymous
聊赠一枝春
Rita
悦耳的怀寒
dawnfrf
OK
if
皖公网安备34019202002308
